Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Study protocol: To investigate effects of highly specialized rehabilitation for patients with multiple sclerosis a randomized controlled trial of a personalized, multidisciplinary intervention.
Neuromyelitis optica.
Copy number variation in pediatric multiple sclerosis.
Neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, AIDS, and multiple sclerosis.
[Anti-MOG antibody in different types of immune-mediated optic neuritis].
Compromised motor imagery ability in individuals with multiple sclerosis and mild physical disability: An ERP study.
Unilateral optic neuritis, scleritis and exudative retinal detachment due to recurrent orbital pseudotumor.
[New and emerging treatments for multiple sclerosis].
Interest in providing multiple sclerosis care and subspecializing in multiple sclerosis among neurology residents.
Multiple deep white matter lesions mimicking multiple sclerosis as an unusual complication of a left atrial myxoma.
Alemtuzumab and multiple sclerosis: Is it safe?
A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca(2+) release from acidic Ca(2+) stores.
Effects of balance-specific exercises on balance, physical activity and quality of life in adults with multiple sclerosis: a pilot investigation.
A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin.
Reduced Retinal Nerve Fiber Layer Thickness and Macular Volume in Pediatric Multiple Sclerosis.
Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys.
Is the IL-10 Promoter Polymorphism at Position -592 Associated with Immune System-Related Diseases?
Frequency of reported European ancestry among multiple sclerosis patients from four cities in the southern and southeastern regions of Brazil.
Treatment of pediatric multiple sclerosis.
Presence of aberrant V<formula>_{H}</formula>6 domains in anti-interferon-γ autoantibodies in multiple sclerosis.
Scope and Applications of Nanomedicines for the Management of Multiple Sclerosis.
Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia.
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.
The new therapeutic landscape in multiple sclerosis: exciting times and new perspectives.
Clinical correlations of motor and somatosensory evoked potentials in neuromyelitis optica.

Pages